Please use this identifier to cite or link to this item: https://doi.org/10.1016/j.jcrc.2013.08.010
DC FieldValue
dc.titleClinically manifest thromboembolic complications of femoral vein catheterization for continuous renal replacement therapy
dc.contributor.authorLipcsey, M.
dc.contributor.authorChua, H.-R.
dc.contributor.authorSchneider, A.G.
dc.contributor.authorRobbins, R.
dc.contributor.authorBellomo, R.
dc.date.accessioned2016-07-08T09:26:10Z
dc.date.available2016-07-08T09:26:10Z
dc.date.issued2014-02
dc.identifier.citationLipcsey, M., Chua, H.-R., Schneider, A.G., Robbins, R., Bellomo, R. (2014-02). Clinically manifest thromboembolic complications of femoral vein catheterization for continuous renal replacement therapy. Journal of Critical Care 29 (1) : 18-23. ScholarBank@NUS Repository. https://doi.org/10.1016/j.jcrc.2013.08.010
dc.identifier.issn08839441
dc.identifier.urihttp://scholarbank.nus.edu.sg/handle/10635/125372
dc.description.abstractPurpose: The safety of femoral vein (FV) catheterization for continuous renal replacement therapy is uncertain. We sought to determine the incidence of clinically manifest venous thromboembolism (VTE) in such patients. Methods: We retrospectively studied patients with femoral high flow catheters (≥. 13F) (December 2005 to February 2011). Discharge diagnostic codes were independently screened for VTE. The incidence of VTE was also independently similarly assessed in a control cohort of patients ventilated for more than 2 days (January 2011 to December 2011) in the same intensive care unit (ICU). Results: We studied 380 patients. Their mean age was 61 years, and 59% were male. The mean Acute Physiology and Chronic Health Evaluation III score was 84; average duration of continuous renal replacement therapy was 74 hours, and 232 patients (61%) survived to hospital discharge with an average length of hospital stay of 22 days. Only 5 patients (1.3%) had clinically manifest VTE after FV catheterization. In the control cohort of 514 ICU patients, the incidence of VTE was 4.4% (P < .05 compared with FV group). Conclusion: The incidence of clinically manifest VTE after FV catheterization with high flow catheters is low and lower to that seen in general ICU patients. © 2014 Elsevier Inc.
dc.description.urihttp://libproxy1.nus.edu.sg/login?url=http://dx.doi.org/10.1016/j.jcrc.2013.08.010
dc.sourceScopus
dc.subjectCatheters
dc.subjectFemoral vein
dc.subjectIntensive care unit
dc.subjectVenous thromboembolism
dc.typeArticle
dc.contributor.departmentMEDICINE
dc.description.doi10.1016/j.jcrc.2013.08.010
dc.description.sourcetitleJournal of Critical Care
dc.description.volume29
dc.description.issue1
dc.description.page18-23
dc.description.codenJCCAE
dc.identifier.isiut000328693000004
Appears in Collections:Staff Publications

Show simple item record
Files in This Item:
There are no files associated with this item.

Google ScholarTM

Check

Altmetric


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.